Trials / Completed
CompletedNCT01145066
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
Modulation of Biomarkers and Gene Expression by Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | borage/echium oil combination | borage/echium oil combination containing 0.85g/day SDA and 1.7g/day GLA |
| DIETARY_SUPPLEMENT | fish oil | 1.6g/day EPA and 1.08g/day DHA |
| DIETARY_SUPPLEMENT | corn oil | contains 4.5 g/day linoleic acid |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-06-16
- Last updated
- 2019-07-18
- Results posted
- 2018-12-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01145066. Inclusion in this directory is not an endorsement.